Martin Grünewald

543 total citations
19 papers, 384 citations indexed

About

Martin Grünewald is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Martin Grünewald has authored 19 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 4 papers in Surgery and 4 papers in Genetics. Recurrent topics in Martin Grünewald's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Platelet Disorders and Treatments (6 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Martin Grünewald is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Platelet Disorders and Treatments (6 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Martin Grünewald collaborates with scholars based in Germany, United States and United Kingdom. Martin Grünewald's co-authors include Martin Grießhammer, O. Gödje, Helmut Mair, Mario Koksch, A. Siegemund, Christiane Güthner, Markus Bangerter, Erhard Seifried, Jan Michiels and Stefanie Schauer and has published in prestigious journals such as Trends in Molecular Medicine, European Journal of Applied Physiology and Journal of Hospital Infection.

In The Last Decade

Martin Grünewald

18 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Grünewald Germany 11 212 118 72 61 56 19 384
Jayne L. Bonan United States 6 285 1.3× 56 0.5× 47 0.7× 71 1.2× 117 2.1× 8 443
AD Michelson United States 9 421 2.0× 46 0.4× 32 0.4× 116 1.9× 65 1.2× 12 590
Machin United Kingdom 7 223 1.1× 79 0.7× 12 0.2× 63 1.0× 62 1.1× 8 359
Elizabeth A. Jaben United States 10 67 0.3× 22 0.2× 21 0.3× 52 0.9× 51 0.9× 13 319
Wilfried Roeloffzen Netherlands 8 65 0.3× 30 0.3× 87 1.2× 42 0.7× 33 0.6× 23 259
José María Raya Spain 8 87 0.4× 45 0.4× 37 0.5× 18 0.3× 60 1.1× 19 214
Jesse I. Spector United States 12 85 0.4× 35 0.3× 26 0.4× 75 1.2× 70 1.3× 22 330
R Silver United States 6 148 0.7× 94 0.8× 24 0.3× 25 0.4× 40 0.7× 7 364
Brynjar Viðarsson Iceland 9 142 0.7× 55 0.5× 13 0.2× 36 0.6× 10 0.2× 21 286
R.A. Henriksen United States 10 267 1.3× 58 0.5× 267 3.7× 98 1.6× 126 2.3× 16 530

Countries citing papers authored by Martin Grünewald

Since Specialization
Citations

This map shows the geographic impact of Martin Grünewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Grünewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Grünewald more than expected).

Fields of papers citing papers by Martin Grünewald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Grünewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Grünewald. The network helps show where Martin Grünewald may publish in the future.

Co-authorship network of co-authors of Martin Grünewald

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Grünewald. A scholar is included among the top collaborators of Martin Grünewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Grünewald. Martin Grünewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Grünewald, Martin, Hans Eberhardt, Peter Martus, et al.. (2020). Ambulatory screening and decontamination to prevent Staphylococcus aureus complications in patients undergoing elective surgery (STAUfrei): study protocol for a controlled intervention study. BMC Infectious Diseases. 20(1). 95–95. 1 indexed citations
3.
Mulder, Edwin, Gilles Clément, Dag Linnarsson, et al.. (2014). Musculoskeletal effects of 5 days of bed rest with and without locomotion replacement training. European Journal of Applied Physiology. 115(4). 727–738. 37 indexed citations
4.
Gödje, O., et al.. (2006). Coagulation Factor XIII Reduces Postoperative Bleeding After Coronary Surgery with Extracorporeal Circulation. The Thoracic and Cardiovascular Surgeon. 54(1). 26–33. 98 indexed citations
5.
Grünewald, Martin, et al.. (2004). The platelet function defect of paroxysmal nocturnal haemoglobinuria. Platelets. 15(3). 145–154. 18 indexed citations
6.
Grünewald, Martin & Martin Grießhammer. (2003). P-selectin modulation in haemostasis: one size fits all?. Trends in Molecular Medicine. 10(1). 9–12. 2 indexed citations
7.
Grünewald, Martin, et al.. (2003). Plasmatic coagulation and fibrinolytic system alterations in PNH. Blood Coagulation & Fibrinolysis. 14(7). 685–695. 31 indexed citations
8.
Grießhammer, Martin, Martin Grünewald, & Jan Michiels. (2003). Acquired Thrombophilia in Pregnancy: Essential Thrombocythemia. Seminars in Thrombosis and Hemostasis. 29(2). 205–212. 22 indexed citations
9.
10.
Grünewald, Martin, et al.. (2002). Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia. Haemophilia. 8(6). 768–775. 35 indexed citations
11.
Grünewald, Martin, et al.. (2001). Acquired haemophilia: experiences with a standardized approach. Haemophilia. 7(2). 164–169. 36 indexed citations
12.
Grießhammer, Martin, Markus Bangerter, & Martin Grünewald. (2001). Current treatment practice for essential thrombocythaemia in adults. Expert Opinion on Pharmacotherapy. 2(3). 385–393. 2 indexed citations
13.
Grünewald, Martin, et al.. (2000). Loco-regional thrombolysis for deep vein thrombosis: fact or fiction? A study of hemostatic parameters. Blood Coagulation & Fibrinolysis. 11(6). 529–536. 6 indexed citations
14.
Bangerter, Markus, et al.. (2000). Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies. European Journal Of Haematology. 65(3). 165–169. 33 indexed citations
15.
Grünewald, Martin, et al.. (2000). Monitoring of haemostatic parameters during thrombolysis with rtPA for deep venous thrombosis: correlation with clinical events. Fibrinolysis & proteolysis. 14(6). 343–350. 1 indexed citations
16.
Grießhammer, Martin, et al.. (1999). Increased Platelet Surface Expression of P-Selectin and Thrombospondin as Markers of Platelet Activation in Essential Thrombocythaemia. Thrombosis Research. 96(3). 191–196. 25 indexed citations
17.
Grünewald, Martin, Matthias Müller, H.-H. Osterhues, et al.. (1997). Double- versus single-bolus thrombolysis with reteplase for acute myocardial infarction: a pharmacokinetic and pharmacodynamic study. Fibrinolysis & proteolysis. 11(3). 137–145. 8 indexed citations
18.
Grünewald, Martin & Erhard Seifried. (1994). Meta-analysis of all available published clinical trials (1958–1990) on thrombolytic therapy for AMI: Relative efficacy of different therapeutic strategies. Fibrinolysis and Proteolysis. 8(2). 67–86. 14 indexed citations
19.
Grünewald, Martin & E. Seifried. (1993). [Laboratory monitoring of thrombolytic therapy in clinical practice and research].. PubMed. 82 Suppl 2. 129–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026